XML 60 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Acquisitions - Additional Information (Details)
9 Months Ended
Aug. 31, 2021
USD ($)
Mar. 01, 2021
USD ($)
Location
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Business Acquisition [Line Items]            
Total purchase consideration, net of cash acquired     $ 1,350,000 $ 748,000    
Goodwill     $ 52,463,000 $ 50,658,000 $ 50,536,000 $ 50,010,000
MedOne            
Business Acquisition [Line Items]            
Acquisition date Aug. 31, 2021          
Total purchase consideration $ 2,000,000.0          
Total purchase consideration, net of cash acquired 1,250,000          
Escrow for potential satisfaction of certain indemnification obligations 250,000          
Contingent consideration fair value 500,000          
Goodwill 1,900,000          
Maximum additional consideration payable $ 1,000,000.0          
MedOne | Volatility            
Business Acquisition [Line Items]            
Contingent consideration, fair value estimation 0.233   0.250      
MedOne | Discount Rate            
Business Acquisition [Line Items]            
Contingent consideration, fair value estimation 0.103   0.103      
AMPM            
Business Acquisition [Line Items]            
Acquisition date   Mar. 01, 2021        
Total purchase consideration   $ 1,100,000        
Total purchase consideration, net of cash acquired   400,000        
Escrow for potential satisfaction of certain indemnification obligations   300,000        
Contingent consideration fair value   400,000        
Goodwill   700,000        
Maximum additional consideration payable   $ 2,100,000        
Number of respiratory products and services locations | Location   9        
AMPM | Trade Names            
Business Acquisition [Line Items]            
Intangible assets   $ 400,000        
AMPM | Volatility            
Business Acquisition [Line Items]            
Contingent consideration, fair value estimation   0.400 0.268      
AMPM | Discount Rate            
Business Acquisition [Line Items]            
Contingent consideration, fair value estimation   0.103 0.103